[Market Focus] Cosmax Rises 7% on Talks with MFDS to Strengthen K-Beauty Competitiveness
The share price of Cosmax is on the rise following discussions with the Ministry of Food and Drug Safety on global regulatory responses.
As of 9:40 a.m. on March 20, 2026, Cosmax was trading at 191,700 won, up 12,500 won (6.98%) from the previous trading day.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The previous day, Cosmax held a meeting at the R&I Center in Pangyo, Seongnam, Gyeonggi Province, with stakeholders including Ahn Youngjin, Director of the Biopharmaceutical and Herbal Medicine Bureau at the Ministry of Food and Drug Safety. Both sides discussed strategies to respond to the introduction of in vitro testing methods for sunscreens. Cosmax became the first company in Korea to introduce automated testing equipment capable of measuring in vitro SPF and PA for sunscreens.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.